ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
Мозговой шторм

Мозговой шторм

Авторы:
Никита Владимирович Соловей,
Игорь Александрович Карпов,
Виктор Васильевич Щерба

Журнал: Non nocere. Новый терапевтический журнал. 2026;(4):40-47.

Прочитано: 156 раз

Резюме

Менингококковая инфекция у лиц старшего возраста.

Дата публикации: 24.04.2026

Литература / References
  1. Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 2022;22(1):380. https://doi.org/10.1186/s12889-022-12795-9
  2. Weil-Olivier C, Taha MK, Leng S, et al. Invasive meningococcal disease in older adults: current perspectives and call for action. Eur Geriatr Med. 2024;15(3):729-741. https://doi.org/10.1007/s41999-024-00969-0
  3. Saboui M, Tsang RS, MacTavish R, et al. Epidemiology of invasive meningococcal disease in Canada, 2012-2019. Can Commun Dis Rep. 2022;48(5):228-236. https://doi.org/10.14745/ccdr.v48i05a06
  4. Taha MK, Weil-Olivier C, Leng S, Dinleyici EC, Yezli S. Meningococcal Disease in Older Adults: Challenges in Diagnosis and Management. Infect Dis Ther. 2026;15(2):443-459. https://doi.org/10.1007/s40121-025-01281-5
  5. Mustapha MM, Marsh JW, Harrison LH. Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine. 2016;34(13):1515-1523. https://doi.org/10.1016/j.vaccine.2016.02.014
  6. Campbell H, Andrews N, Parikh S, et al. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182-189. https://doi.org/10.1016/j.jinf.2019.11.001
  7. Taha S, Deghmane AE, Taha MK. Recent increase in atypical presentations of invasive meningococcal disease in France. BMC Infect Dis. 2024;24(1):640. https://doi.org/10.1186/s12879-024-09547-y
  8. Deghmane AE, Taha MK. Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic. Microorganisms. 2022;10(5):907. https://doi.org/10.3390/microorganisms10050907
  9. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6): e360–e370. https://doi.org/10.1016/S2589-7500(21)00077-7
  10. Taha S, Hong E, Denizon M, et al. The rapid rebound of invasive meningococcal disease in France at the end of 2022. J Infect Public Health. 2023;16(12):1954-1960. https://doi.org/10.1016/j.jiph.2023.10.001
  11. Kang HM, Kang JH. Effects of nasopharyngeal microbiota in respiratory infections and allergies. Clin Exp Pediatr. 2021;64(11):543-551. https://doi.org/10.3345/cep.2020.01452
  12. Allen JC, Toapanta FR, Chen W, Tennant SM. Understanding immunosenescence and its impact on vaccination of older adults. Vaccine. 2020;38(52):8264-8272. https://doi.org/10.1016/j.vaccine.2020.11.002
  13. Lundbo LF, Harboe ZB, Sandholdt H, et al. Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults. Clin Infect Dis. 2022;75(1):125-130. https://doi.org/10.1093/cid/ciab856
  14. Lundbo LF, Harboe ZB, Sandholdt H, et al. Serogroup B Invasive Meningococcal Disease in Older Adults Identified by Genomic Surveillance, England, 2022-2023. Emerg Infect Dis. 2024;30(5):1009-1012. https://doi.org/10.3201/eid3005.231714
  15. Lawler J, Lucidarme J, Parikh S, et al. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015. Euro Surveill. 2019;24(23):1900070. https://doi.org/10.2807/1560-7917.ES.2019.24.23.1900070
  16. Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60-64. https://doi.org/10.1016/j.ijid.2016.04.007
  17. Willerton L, Lucidarme J, Campbell H, et al. Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex. J Infect. 2020;81(4):575-584. https://doi.org/10.1016/j.jinf.2020.08.030
  18. Vachon MS, Barret AS, Lucidarme J, et al. Cases of Meningococcal Disease Associated with Travel to Saudi Arabia for Umrah Pilgrimage – United States, United Kingdom, and France, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(22):514-516. https://doi.org/10.15585/mmwr.mm7322e1
  19. Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. https://doi.org/10.1017/S0950268819002152
  20. Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis (Lond). 2022;54(1):1-7. https://doi.org/10.1080/23744235.2021.1971289
  21. Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia (Nathan). 2019;11:3. https://doi.org/10.1186/s41479-019-0062-0
  22. Guiddir T, Gros M, Hong E, et al. Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease. Clin Infect Dis. 2018;67(8):1220-1227.
  23. Kelly SJ, Robertson RW. Neisseria meningitidis peritonitis. ANZ J Surg. 2004;74(3):182-183. https://doi.org/10.1046/j.1445-1433.2003.02850.x
  24. Tomezzoli S, Juárez Mdel V, Rossi SI, Lema DA, Barbaro CR, Fiorini S. [Acute abdomen as initial manifestation of meningococcemia]. Arch Argent Pediatr. 2008;106(3):260-263. https://doi.org/10.1590/S0325-00752008000300012
  25. Tomezzoli S, JuÁrez Mdel V, Rossi SI, Lema DA, Barbaro CR, Fiorini S. An analysis of Neisseria meningitidis strains causing meningococcal septic arthritis in England and Wales: 2010-2020. J Infect. 2022;85(4):390-396. https://doi.org/10.1016/j.jinf.2022.07.019
  26. Zimmermann T, Chmiel C. Neisseria meningitidis sepsis in a patient with acute epiglottitis and respiratory failure. BMJ Case Rep. 2018;2018: bcr2017223388. https://doi.org/10.1136/bcr-2017-223388
  27. Vienne P, Ducos-Galand M, Guiyoule A, et al. The Role of Particular Strains of Neisseria meningitidis in Meningococcal Arthritis, Pericarditis, and Pneumonia. Clinical Infectious Diseases. 2003;37(12):1639-1642. https://doi.org/10.1086/379719
  28. Lesourd A, Magne N, Soares A, et al. Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature. BMC Infect Dis. 2018;18(1):226. https://doi.org/10.1186/s12879-018-3119-4
  29. Van de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. Lancet. 2021;398(10306):1171-1183. https://doi.org/10.1016/S0140-6736(21)00883-7
  30. Crosswell JM, Nicholson WR, Lennon DR. Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration. J Paediatr Child Health. 2006;42(4):170-173. https://doi.org/10.1111/j.1440-1754.2006.00824.x
  31. Lin HL, Chen HM, Lin CY, Chen CC. Accuracy of antigen tests for meningococcal meningitis in cerebrospinal fluid: A diagnostic meta-analysis. Trop Med Int Health. 2023;28(10):797-805. https://doi.org/10.1111/tmi.13928
  32. Haddar CH, Terrade A, Verhoeven P, et al. Validation of a New Rapid Detection Test for Detection of Neisseria meningitidis A/C/W/X/YAntigens in Cerebrospinal Fluid. J Clin Microbiol. 2020;58(3):e01699-19. https://doi.org/10.1128/JCM.01699-19
  33. Bryant PA, Li HY, Zaia A, et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol. 2004;42(7):2919-2925. https://doi.org/10.1128/JCM.42.7.2919-2925.2004
  34. Guiducci S, Moriondo M, Nieddu F, et al. Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases? PLoS One. 2019;14(3):e0212922. https://doi.org/10.1371/journal.pone.0212922
  35. Obaro S, Hassan-Hanga F, Medugu N, et al. Comparison of bacterial culture with BioFire® FilmArray® multiplex PCR screening of archived cerebrospinal fluid specimens from children with suspected bacterial meningitis in Nigeria. BMC Infect Dis. 2023;23(1):641. https://doi.org/10.1186/s12879-023-08645-7
  36. Waterfield T, Fairley D, Blackwood B, McKenna J, Shields MD. A systematic review of the diagnostic accuracy of Loop-mediated-isothermal AMPlification (LAMP) in the diagnosis of invasive meningococcal disease in children. BMC Pediatr. 2019;19(1):49. https://doi.org/10.1186/s12887-019-1403-0
  37. Borrow R, Findlow J. The important lessons lurking in the history of meningococcal epidemiology. Expert Rev Vaccines. 2024;23(1):445-462. https://doi.org/10.1080/14760584.2024.2329618
  38. Van de Beek D, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin. Microbiol. Infect. 2016;22 Suppl 3:S37-62. https://doi.org/10.1016/j.cmi.2016.01.007
  39. Zouheir Y, Atany T, Boudebouch N. Emergence and spread of resistant N. meningitidis implicated in invasive meningococcal diseases during the past decade (2008-2017). J Antibiot (Tokyo). 2019;72(3):185-188. https://doi.org/10.1038/s41429-018-0125-0
  40. Saito R, Nakajima J, Prah I, et al. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan. Microbiol Spectr. 2022;10(3):e0062722. https://doi.org/10.1128/spectrum.00627-22
  41. Deghmane AE, Hong E, Taha MK. Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis. Antibiotics (Basel). 2023;12(6):992. https://doi.org/10.3390/antibiotics12060992
  42. Potts CC, Retchless AC, McNamara LA, et al. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup YNeisseria meningitidis in the United States. Clin Infect Dis. 2021;73(7):1185-1193. https://doi.org/10.1093/cid/ciab358
  43. Willerton L, Lucidarme J, Walker A, et al. Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England. Vaccine. 2021;39(19):2719-2729. https://doi.org/10.1016/j.vaccine.2021.03.002
  44. McNamara LA, Potts C, Blain AE, et al. Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates – United States, 2019-2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):735-739. https://doi.org/10.15585/mmwr.mm6924a2
  45. Deghmane AE, Taha S, Taha MK. Meningococcal resistance to ciprofloxacin is not rare anymore. J Antimicrob Chemother. 2025;80(1):311-313. https://doi.org/10.1093/jac/dkae433
  46. Zarbock SD, DePriest KL, Koepp BM. A case report of serotype W135 Neisseria meningitidis epiglottitis in the United States and review of twelve adult cases of meningococcal epiglottitis. IDCases. 2018;14:e00466. https://doi.org/10.1016/j.idcr.2018.e00466
  47. Schwam E, Cox J. Fulminant meningococcal supraglottitis: An emerging infectious syndrome? Emerg Infect Dis. 1999;5(3):464-467. https://doi.org/10.3201/eid0503.990323
  48. Morello BR, Milazzo A, Marshall HS, Giles LC. Lessons for and from the COVID-19 pandemic response – An appraisal of guidance for the public health management of Invasive Meningococcal Disease. J Infect Public Health. 2021;14(8):1069-1074. https://doi.org/10.1016/j.jiph.2021.06.014
  49. Berry I, Rubis AB, Howie RL, et al. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance – United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(5):99-103. https://doi.org/10.15585/mmwr.mm7305a2
  50. Bove C, Baldock RA, Champigneulle O, Martin L, Bennett CL. Fluoroquinolones: old drugs, putative new toxicities. Expert Opin Drug Saf. 2022;21(11):1365-1378. https://doi.org/10.1080/14740338.2022.2147924
  51. Public health management of sporadic cases of invasive meningococcal disease and their contacts [Electronic resource] / European Center for Disease Prevention and Control (ECDC).– Stockholm: ECDC, 2010 (access date: 03/02/2026). https://www.ecdc.europa.eu/en/publications-data/public-health-management-sporadic-cases-invasive-meningococcal-disease-and-their
  52. Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis. Vaccine. 2019;37(21):2768-2782. https://doi.org/10.1016/j.vaccine.2019.04.020
  53. Guedes S, Bricout H, Langevin E, Tong S, Bertrand-Gerentes I. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis. BMC Public Health. 2022;22(1):521. https://doi.org/10.1186/s12889-022-12933-3
  54. Beebeejaun K, Parikh SR, Campbell H, et al. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015. J Infect. 2020;80(3):286-290. https://doi.org/10.1016/j.jinf.2019.12.008
  55. Sadarangani M, Scheifele DW, Halperin SA, et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60(8):e27-35. https://doi.org/10.1093/cid/civ028
  56. Olbrich KJ, Müller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers. Infect Dis Ther. 2018;7(4):421-438. https://doi.org/10.1007/s40121-018-0213-2
  57. Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003;51(4)451-458. https://doi.org/10.1046/j.1532-5415.2003.51152.x
  58. Al-Janabi H, Van Exel J, Brouwer W, et al. Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis. Health Econ. 2016;25(12):1529-1544. https://doi.org/10.1002/hec.3259
  59. Shen J, Bouée S, Aris E, Emery C, Beck EC. Correction to: Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM). Infect Dis Ther. 2022;11(1):263-264. https://doi.org/10.1007/s40121-021-00584-7
  60. Taha MK, Bekkat-Berkani R, Abitbol V. Changing patterns of invasive meningococcal disease and future immunization strategies. Hum Vaccin Immunother. 2023;19(1):2186111. https://doi.org/10.1080/21645515.2023.2186111
  61. Sulis G, Horn M, Borrow R, Basta NE. A comparison of national vaccination policies to prevent serogroup B meningococcal disease. Vaccine. 2022;(26):3647-3654. https://doi.org/10.1016/j.vaccine.2022.04.101
  62. Herrera-Restrepo O, Kuang Y, D’Angelo J, Bekkat-Berkani R, Clements DE, Uyei J. Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit. Infect Dis Ther. 2023;12(5):1265-1282. https://doi.org/10.1007/s40121-023-00793-2
  63. Campbell H, Andrews N, Parikh SR, et al. Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study. Lancet Child Adolesc Health. 2022;6(2):96-105. https://doi.org/10.1016/S2352-4642(21)00335-7
  64. Martinón-Torres F, Bertrand-Gerentes I, Oster P. A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Rev Vaccines. 2021;20(9):1123-1146. https://doi.org/10.1080/14760584.2021.1964962
  65. Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against Meningococcal Diseases. Microorganisms. 2020;8(10):1521. https://doi.org/10.3390/microorganisms8101521
  66. Safadi MAP, Martinón-Torres F, Serra L, Burman C, Presa J. Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Rev Vaccines. 2021;20(4):401-414. https://doi.org/10.1080/14760584.2021.1899820
  67. Shah HA, Jutlla G, Herrera-Restrepo O, et al. Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. Pharmacoeconomics. 2025;43(3):311-329. https://doi.org/10.1007/s40273-024-01439-y
  68. Nolan T, Bhusal C, Beran J, et al. Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial. Lancet Infect Dis. 2025;25(5):560-573. https://doi.org/10.1016/S1473-3099(24)00667-4
  69. Bell E, Neri M, Steuten L. Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward. Appl Health Econ Health Policy. 2022;20(1):105-117. https://doi.org/10.1007/s40258-021-00683-z
slide-cover
slide-cover
slide-cover
slide-cover
Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29

  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12

  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru

  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026